Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD Study.

RATIONALE Chronic obstructive pulmonary disease (COPD) remains undiagnosed in many individuals with persistent airflow limitation. These individuals may be susceptible to exacerbation-like respiratory events that consume health care resources. OBJECTIVES To compare exacerbation-like respiratory events, event prevalence, and differences in the odds of using medication and/or health services between subjects with diagnosed and undiagnosed COPD. METHODS Subjects sampled from the general population participating in the CanCOLD (Canadian Cohort Obstructive Lung Disease) study, with at least 12 months of exacerbation-event follow-up who were classified as having physician-diagnosed or undiagnosed COPD were assessed. Exacerbation-like respiratory events were captured using a questionnaire administered every 3 months. MEASUREMENTS AND MAIN RESULTS A total of 355 subjects were undiagnosed and 150 were diagnosed with COPD. Undiagnosed subjects were less symptomatic and functionally impaired, had been prescribed fewer respiratory medications, and had better health status. The incidence of reported exacerbation-like events was higher in diagnosed subjects and increased in both groups with the severity of airflow obstruction. Although subjects with diagnosed COPD were more often prescribed medication for exacerbation events, health service use for exacerbation events was similar in both groups. CONCLUSIONS Most subjects with COPD in Canada remain undiagnosed. These subjects are less symptomatic and impaired, which may partly explain lack of diagnosis. Although patients with undiagnosed COPD experience fewer exacerbations than those with diagnosed COPD, they use a similar amount of health services for exacerbation events; thus, the overall health system burden of exacerbations in those with undiagnosed COPD is considerable.

[1]  Meilan K. Han,et al.  Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality. , 2015, Annals of the American Thoracic Society.

[2]  P. Burney,et al.  Determinants of underdiagnosis of COPD in national and international surveys. , 2015, Chest.

[3]  J. Barberà,et al.  Characterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation , 2015, BMC Pulmonary Medicine.

[4]  F. Maltais,et al.  Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study , 2014 .

[5]  Andrea Benedetti,et al.  Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the Need for Longitudinal Observational Studies in COPD , 2014, COPD.

[6]  F. Maltais,et al.  Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study , 2013 .

[7]  J. Wedzicha,et al.  Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease , 2013, BMC Medicine.

[8]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[9]  L. Boulet,et al.  Major care gaps in asthma, sleep and chronic obstructive pulmonary disease: a road map for knowledge translation. , 2013, Canadian respiratory journal.

[10]  J. Wedzicha,et al.  Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations. , 2012, American journal of respiratory and critical care medicine.

[11]  J. Bourbeau,et al.  Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada. , 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[12]  J. Walters,et al.  Factors associated with misdiagnosis of COPD in primary care. , 2011, Primary care respiratory journal : journal of the General Practice Airways Group.

[13]  D. Mannino,et al.  COPD in Never Smokers , 2011, Chest.

[14]  F. Maltais,et al.  Effects of written action plan adherence on COPD exacerbation recovery , 2010, Thorax.

[15]  J. Wedzicha,et al.  Susceptibility to exacerbation in chronic obstructive pulmonary disease. , 2010, The New England journal of medicine.

[16]  D. Fitzmaurice,et al.  Case finding for chronic obstructive pulmonary disease: a model for optimising a targeted approach , 2010, Thorax.

[17]  Gordon H. Guyatt,et al.  Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care , 2010, Canadian Medical Association Journal.

[18]  J. Bourbeau,et al.  Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year , 2009, European Respiratory Journal.

[19]  J. Soriano,et al.  Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities , 2009, Thorax.

[20]  W. MacNee,et al.  Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) , 2008, European Respiratory Journal.

[21]  J. Bourbeau,et al.  Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. , 2008, American journal of respiratory and critical care medicine.

[22]  M. Beauchesne,et al.  Asthma worsenings: approaches to prevention and management from the Asthma Worsenings Working Group. , 2008, Canadian respiratory journal.

[23]  J. Bourbeau,et al.  Impact on patients’ health status following early identification of a COPD exacerbation , 2007, European Respiratory Journal.

[24]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[25]  S. Ramsey,et al.  Chronic obstructive pulmonary disease, risk factors, and outcome trials: comparisons with cardiovascular disease. , 2006, Proceedings of the American Thoracic Society.

[26]  A. Lindberg,et al.  Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. , 2006, Respiratory medicine.

[27]  M. Martínez-García,et al.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease , 2005, Thorax.

[28]  S. Spencer,et al.  Impact of preventing exacerbations on deterioration of health status in COPD , 2004, European Respiratory Journal.

[29]  A. Pont,et al.  Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study , 2004, Thorax.

[30]  E. Wouters The burden of COPD in The Netherlands: results from the Confronting COPD survey. , 2003, Respiratory medicine.

[31]  T. Seemungal,et al.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.

[32]  M. Miravitlles,et al.  Factors Associated with Increased Risk of Exacerbation and Hospital Admission in a Cohort of Ambulatory COPD Patients: A Multiple Logistic Regression Analysis , 2000, Respiration.

[33]  S. Spencer,et al.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.

[34]  S. Ramsey,et al.  The economic burden of COPD. , 2000, Chest.

[35]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.